The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Silk Fibroin (SF) Market Research Report 2025
Synopsis
Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
The global Silk Fibroin (SF) market was valued at US$ 29 million in 2023 and is anticipated to reach US$ 43 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Global 5 largest manufacturers of Silk Fibroin (SF) are Croda, Hangzhou Lin Ran Bio-tech, Huzhou Xintiansi Bio-tech, LANXESS and Seidecosa, which make up about 58%. Among them, Croda is the leader with about 18% market share.
China is the largest market, with a share over 35%, followed by Europe and North America, with the share about 32% and 10%. In terms of product type, Silk Peptide occupy the largest share of the total market, about 40%. And in terms of application, the largest application is Cosmetic & Personal Care, followed by Biomedical and Supplements.
This report aims to provide a comprehensive presentation of the global market for Silk Fibroin (SF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Silk Fibroin (SF).
Report Scope
The Silk Fibroin (SF) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Silk Fibroin (SF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Silk Fibroin (SF) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Huzhou Xintiansi Bio-tech
LANXESS
Croda
Huzhou Xintiansi Bio-tech
Zhejiang Xingyue Biotechnology
Chongqing Haifan Biochemical
Zhejiang Silk Seekers
Seidecosa
Suzhou Suhao Bio
Caresilk
Kelisema Srl
Segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Segment by Application
Cosmetic & Personal Care
Biomedical
Supplements
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Silk Fibroin (SF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Silk Fibroin (SF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
The global Silk Fibroin (SF) market was valued at US$ 29 million in 2023 and is anticipated to reach US$ 43 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Global 5 largest manufacturers of Silk Fibroin (SF) are Croda, Hangzhou Lin Ran Bio-tech, Huzhou Xintiansi Bio-tech, LANXESS and Seidecosa, which make up about 58%. Among them, Croda is the leader with about 18% market share.
China is the largest market, with a share over 35%, followed by Europe and North America, with the share about 32% and 10%. In terms of product type, Silk Peptide occupy the largest share of the total market, about 40%. And in terms of application, the largest application is Cosmetic & Personal Care, followed by Biomedical and Supplements.
This report aims to provide a comprehensive presentation of the global market for Silk Fibroin (SF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Silk Fibroin (SF).
Report Scope
The Silk Fibroin (SF) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Silk Fibroin (SF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Silk Fibroin (SF) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Huzhou Xintiansi Bio-tech
LANXESS
Croda
Huzhou Xintiansi Bio-tech
Zhejiang Xingyue Biotechnology
Chongqing Haifan Biochemical
Zhejiang Silk Seekers
Seidecosa
Suzhou Suhao Bio
Caresilk
Kelisema Srl
Segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Segment by Application
Cosmetic & Personal Care
Biomedical
Supplements
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Silk Fibroin (SF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Silk Fibroin (SF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Silk Fibroin (SF) Market Overview
1.1 Product Overview and Scope of Silk Fibroin (SF)
1.2 Silk Fibroin (SF) Segment by Type
1.2.1 Global Silk Fibroin (SF) Market Value Comparison by Type (2024-2030)
1.2.2 Silk Fibroin Powder
1.2.3 Silk Amino Acids
1.2.4 Silk Peptide
1.3 Silk Fibroin (SF) Segment by Application
1.3.1 Global Silk Fibroin (SF) Market Value by Application: (2024-2030)
1.3.2 Cosmetic & Personal Care
1.3.3 Biomedical
1.3.4 Supplements
1.4 Global Silk Fibroin (SF) Market Size Estimates and Forecasts
1.4.1 Global Silk Fibroin (SF) Revenue 2019-2030
1.4.2 Global Silk Fibroin (SF) Sales 2019-2030
1.4.3 Global Silk Fibroin (SF) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Silk Fibroin (SF) Market Competition by Manufacturers
2.1 Global Silk Fibroin (SF) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Silk Fibroin (SF) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Silk Fibroin (SF) Average Price by Manufacturers (2019-2024)
2.4 Global Silk Fibroin (SF) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Silk Fibroin (SF), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Silk Fibroin (SF), Product Type & Application
2.7 Silk Fibroin (SF) Market Competitive Situation and Trends
2.7.1 Silk Fibroin (SF) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Silk Fibroin (SF) Players Market Share by Revenue
2.7.3 Global Silk Fibroin (SF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Silk Fibroin (SF) Retrospective Market Scenario by Region
3.1 Global Silk Fibroin (SF) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Silk Fibroin (SF) Global Silk Fibroin (SF) Sales by Region: 2019-2030
3.2.1 Global Silk Fibroin (SF) Sales by Region: 2019-2024
3.2.2 Global Silk Fibroin (SF) Sales by Region: 2025-2030
3.3 Global Silk Fibroin (SF) Global Silk Fibroin (SF) Revenue by Region: 2019-2030
3.3.1 Global Silk Fibroin (SF) Revenue by Region: 2019-2024
3.3.2 Global Silk Fibroin (SF) Revenue by Region: 2025-2030
3.4 North America Silk Fibroin (SF) Market Facts & Figures by Country
3.4.1 North America Silk Fibroin (SF) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Silk Fibroin (SF) Sales by Country (2019-2030)
3.4.3 North America Silk Fibroin (SF) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Silk Fibroin (SF) Market Facts & Figures by Country
3.5.1 Europe Silk Fibroin (SF) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Silk Fibroin (SF) Sales by Country (2019-2030)
3.5.3 Europe Silk Fibroin (SF) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Silk Fibroin (SF) Market Facts & Figures by Country
3.6.1 Asia Pacific Silk Fibroin (SF) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Silk Fibroin (SF) Sales by Country (2019-2030)
3.6.3 Asia Pacific Silk Fibroin (SF) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Silk Fibroin (SF) Market Facts & Figures by Country
3.7.1 Latin America Silk Fibroin (SF) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Silk Fibroin (SF) Sales by Country (2019-2030)
3.7.3 Latin America Silk Fibroin (SF) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Silk Fibroin (SF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Silk Fibroin (SF) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Silk Fibroin (SF) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Silk Fibroin (SF) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Silk Fibroin (SF) Sales by Type (2019-2030)
4.1.1 Global Silk Fibroin (SF) Sales by Type (2019-2024)
4.1.2 Global Silk Fibroin (SF) Sales by Type (2025-2030)
4.1.3 Global Silk Fibroin (SF) Sales Market Share by Type (2019-2030)
4.2 Global Silk Fibroin (SF) Revenue by Type (2019-2030)
4.2.1 Global Silk Fibroin (SF) Revenue by Type (2019-2024)
4.2.2 Global Silk Fibroin (SF) Revenue by Type (2025-2030)
4.2.3 Global Silk Fibroin (SF) Revenue Market Share by Type (2019-2030)
4.3 Global Silk Fibroin (SF) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Silk Fibroin (SF) Sales by Application (2019-2030)
5.1.1 Global Silk Fibroin (SF) Sales by Application (2019-2024)
5.1.2 Global Silk Fibroin (SF) Sales by Application (2025-2030)
5.1.3 Global Silk Fibroin (SF) Sales Market Share by Application (2019-2030)
5.2 Global Silk Fibroin (SF) Revenue by Application (2019-2030)
5.2.1 Global Silk Fibroin (SF) Revenue by Application (2019-2024)
5.2.2 Global Silk Fibroin (SF) Revenue by Application (2025-2030)
5.2.3 Global Silk Fibroin (SF) Revenue Market Share by Application (2019-2030)
5.3 Global Silk Fibroin (SF) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Huzhou Xintiansi Bio-tech
6.1.1 Huzhou Xintiansi Bio-tech Corporation Information
6.1.2 Huzhou Xintiansi Bio-tech Description and Business Overview
6.1.3 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Product Portfolio
6.1.5 Huzhou Xintiansi Bio-tech Recent Developments/Updates
6.2 LANXESS
6.2.1 LANXESS Corporation Information
6.2.2 LANXESS Description and Business Overview
6.2.3 LANXESS Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LANXESS Silk Fibroin (SF) Product Portfolio
6.2.5 LANXESS Recent Developments/Updates
6.3 Croda
6.3.1 Croda Corporation Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Silk Fibroin (SF) Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 Huzhou Xintiansi Bio-tech
6.4.1 Huzhou Xintiansi Bio-tech Corporation Information
6.4.2 Huzhou Xintiansi Bio-tech Description and Business Overview
6.4.3 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Product Portfolio
6.4.5 Huzhou Xintiansi Bio-tech Recent Developments/Updates
6.5 Zhejiang Xingyue Biotechnology
6.5.1 Zhejiang Xingyue Biotechnology Corporation Information
6.5.2 Zhejiang Xingyue Biotechnology Description and Business Overview
6.5.3 Zhejiang Xingyue Biotechnology Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Xingyue Biotechnology Silk Fibroin (SF) Product Portfolio
6.5.5 Zhejiang Xingyue Biotechnology Recent Developments/Updates
6.6 Chongqing Haifan Biochemical
6.6.1 Chongqing Haifan Biochemical Corporation Information
6.6.2 Chongqing Haifan Biochemical Description and Business Overview
6.6.3 Chongqing Haifan Biochemical Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chongqing Haifan Biochemical Silk Fibroin (SF) Product Portfolio
6.6.5 Chongqing Haifan Biochemical Recent Developments/Updates
6.7 Zhejiang Silk Seekers
6.6.1 Zhejiang Silk Seekers Corporation Information
6.6.2 Zhejiang Silk Seekers Description and Business Overview
6.6.3 Zhejiang Silk Seekers Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhejiang Silk Seekers Silk Fibroin (SF) Product Portfolio
6.7.5 Zhejiang Silk Seekers Recent Developments/Updates
6.8 Seidecosa
6.8.1 Seidecosa Corporation Information
6.8.2 Seidecosa Description and Business Overview
6.8.3 Seidecosa Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Seidecosa Silk Fibroin (SF) Product Portfolio
6.8.5 Seidecosa Recent Developments/Updates
6.9 Suzhou Suhao Bio
6.9.1 Suzhou Suhao Bio Corporation Information
6.9.2 Suzhou Suhao Bio Description and Business Overview
6.9.3 Suzhou Suhao Bio Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Suzhou Suhao Bio Silk Fibroin (SF) Product Portfolio
6.9.5 Suzhou Suhao Bio Recent Developments/Updates
6.10 Caresilk
6.10.1 Caresilk Corporation Information
6.10.2 Caresilk Description and Business Overview
6.10.3 Caresilk Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Caresilk Silk Fibroin (SF) Product Portfolio
6.10.5 Caresilk Recent Developments/Updates
6.11 Kelisema Srl
6.11.1 Kelisema Srl Corporation Information
6.11.2 Kelisema Srl Silk Fibroin (SF) Description and Business Overview
6.11.3 Kelisema Srl Silk Fibroin (SF) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kelisema Srl Silk Fibroin (SF) Product Portfolio
6.11.5 Kelisema Srl Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Silk Fibroin (SF) Industry Chain Analysis
7.2 Silk Fibroin (SF) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Silk Fibroin (SF) Production Mode & Process
7.4 Silk Fibroin (SF) Sales and Marketing
7.4.1 Silk Fibroin (SF) Sales Channels
7.4.2 Silk Fibroin (SF) Distributors
7.5 Silk Fibroin (SF) Customers
8 Silk Fibroin (SF) Market Dynamics
8.1 Silk Fibroin (SF) Industry Trends
8.2 Silk Fibroin (SF) Market Drivers
8.3 Silk Fibroin (SF) Market Challenges
8.4 Silk Fibroin (SF) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
